Skip to main content

Table 2 Comparison of study population by follow-up period

From: Time to follow up after an abnormal finding in organized gastric cancer screening in Korea

Variables   Follow-up time <90 days Follow-up time ≥90 days  
   Number (%) P -value
Total   2059 (86.1) 332 (13.9)  
Age 40–49 328 (91.1) 32 (8.9) <0.0001
  50–59 544 (89.6) 63 (10.4)  
  60–69 806 (85.5) 137 (14.5)  
  70+ 381 (79.2) 100 (20.8)  
Sex Male 1418 (86.4) 223 (13.6) 0.5356
  Female 641 (85.5) 109 (14.5)  
Result Suspicion of cancer 397 (59.4) 271 (40.6) <0.0001
  Cancer 1662 (96.5) 61 (3.5)  
Health Insurance Medical Aids 103 (71.0) 42 (29.0) <0.0001
  NHI premium in the lower 50% 860 (90.2) 94 (9.9)  
  NHI premium in the upper 50% 1096 (84.8) 196 (15.2)  
Method UGIS 235 (58.6) 166 (41.4) <0.0001
  EGD 1824 (91.7) 166 (8.3)  
Symptom     
Fatigue No 1708 (86.2) 273 (13.8) 0.7454
  Yes 351 (85.6) 59 (14.4)  
Abdominal pain and discomfort No 1449 (84.6) 263 (15.4) 0.0009
  Yes 610 (89.8) 69 (10.2)  
Abdominal bloating No 1783 (85.6) 300 (14.4) 0.0573
  Yes 276 (89.6) 32 (10.4)  
Indigestion No 1807 (85.9) 297 (14.1) 0.3774
  Yes 252 (87.8) 35 (12.2)  
Changes in bowel habits No 1805 (86.2) 289 (13.8) 0.7523
  Yes 254 (85.5) 43 (14.5)  
Weight loss No 1966 (86.1) 317 (13.9) 0.9991
  Yes 93 (86.1) 15 (13.9)